Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 2416192, 9 pages
http://dx.doi.org/10.1155/2016/2416192
Clinical Study

Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells

1Dipartimento di Chirurgia “P. Valdoni”, Sapienza University of Rome, Via Giovanni Maria Lancisi 2, 00161 Roma, Italy
2Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Received 31 July 2015; Accepted 12 November 2015

Academic Editor: Norbert Pallua

Copyright © 2016 Maria Giuseppina Onesti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Poole, N. J. MacIntyre, and H. N. deBoer, “Evidence-based management of hand and mouth disability in a woman living with diffuse systemic sclerosis (Scleroderma),” Physiotherapy Canada, vol. 65, no. 4, pp. 317–320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Au, M. D. Mayes, P. Maranian et al., “Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study,” Arthritis Care & Research, vol. 62, no. 12, pp. 1772–1778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. Coleman, “Structural fat grafts: the ideal filler?” Clinics in Plastic Surgery, vol. 28, no. 1, pp. 111–119, 2001. View at Google Scholar · View at Scopus
  4. S. R. Coleman and A. P. Saboeiro, “Fat grafting to the breast revisited: safety and efficacy,” Plastic and Reconstructive Surgery, vol. 119, no. 3, pp. 775–787, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Locke, J. Windsor, and P. R. Dunbar, “Human adipose-derived stem cells: isolation, characterization and applications in surgery,” ANZ Journal of Surgery, vol. 79, no. 4, pp. 235–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Fiorina, M. Jurewicz, A. Augello et al., “Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes,” Journal of Immunology, vol. 183, no. 2, pp. 993–1004, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Jurewicz, S. Yang, A. Augello et al., “Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes,” Diabetes, vol. 59, no. 12, pp. 3139–3147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Fioramonti, M. G. Onesti, C. Marchese, S. Carella, S. Ceccarelli, and N. Scuderi, “Autologous cultured melanocytes in vitiligo treatment comparison of two techniques to prepare the recipient site: erbium-doped yttrium aluminum garnet laser versus dermabrasion,” Dermatologic Surgery, vol. 38, no. 5, pp. 809–812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. T. Masi, “Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee,” Arthritis & Rheumatism, vol. 23, no. 5, pp. 581–590, 1980. View at Publisher · View at Google Scholar
  10. D. Khanna and P. A. Merkel, “Outcome measures in systemic sclerosis: an update on instruments and current research,” Current Rheumatology Reports, vol. 9, no. 2, pp. 151–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. P. Rodnan, E. Lipinski, and J. Luksick, “Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma,” Arthritis and Rheumatism, vol. 22, no. 2, pp. 130–140, 1979. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Dugar, R. Woolford, M. J. Ahern, M. D. Smith, and P. J. Roberts-Thomson, “Use of electronic tonometer to assess skin hardness in systemic sclerosis: a pilot cross-sectional study,” Clinical and Experimental Rheumatology, vol. 27, no. 3, supplement 54, p. 70, 2009. View at Google Scholar · View at Scopus
  13. D. N. H. Enomoto, J. R. Mekkes, P. M. M. Bossuyt, R. Hoekzema, and J. D. Bos, “Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma,” Journal of the American Academy of Dermatology, vol. 35, no. 3, part 1, pp. 381–387, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Y. Kissin, A. M. Schiller, R. B. Gelbard et al., “Durometry for the assessment of skin disease in systemic sclerosis,” Arthritis Care and Research, vol. 55, no. 4, pp. 603–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Falanga and B. Bucalo, “Use of a durometer to assess skin hardness,” Journal of the American Academy of Dermatology, vol. 29, no. 1, pp. 47–51, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. K. W. Moon, R. Song, J. H. Kim, E. Y. Lee, E. B. Lee, and Y. W. Song, “The correlation between durometer score and modified Rodnan skin score in systemic sclerosis,” Rheumatology International, vol. 32, no. 8, pp. 2465–2470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Del Rosso, M. Boldrini, D. D'Agostino et al., “Health-related quality of life in systemic sclerosis as measured by the short form 36: relationship with clinical and biologic markers,” Arthritis Care and Research, vol. 51, no. 3, pp. 475–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Poole and V. D. Steen, “The use of the health assessment questionnaire (HAQ) to determine physical disability in systemic sclerosis,” Arthritis Care and Research, vol. 4, no. 1, pp. 27–31, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. V. D. Steen and T. A. Medsger Jr., “The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time,” Arthritis and Rheumatism, vol. 40, no. 11, pp. 1984–1991, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. L. M. Brower and J. L. Poole, “Reliability and validity of the Duruöz Hand Index in persons with systemic sclerosis (scleroderma),” Arthritis & Rheumatism, vol. 51, no. 5, pp. 805–809, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Sandqvist and M. Eklund, “Validity of HAMIS: a test of hand mobility in scleroderma,” Arthritis Care and Research, vol. 13, no. 6, pp. 382–387, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. R. E. Wood and P. Lee, “Analysis of the oral manifestations of systemic sclerosis (scleroderma),” Oral Surgery, Oral Medicine, Oral Pathology, vol. 65, no. 2, pp. 172–178, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Marmary, R. Glaiss, and S. Pisanty, “Scleroderma: oral manifestations,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 52, no. 1, pp. 32–37, 1981. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Tanturri De Horatio, E. Tirri, R. Valletta, G. Tirri, and S. Rengo, “Mouth opening in patients with systemic sclerosis: base analysis and during follow-up,” Minerva Stomatologica, vol. 49, no. 9, pp. 409–413, 2000. View at Google Scholar · View at Scopus
  25. S. M. Bongi, A. Del Rosso, I. Miniati et al., “The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients,” Rheumatology International, vol. 32, no. 9, pp. 2785–2790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Nagy, J. Kovács, M. Zeher, and L. Czirják, “Analysis of the oral manifestations of systemic sclerosis,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 77, no. 2, pp. 141–146, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Albilia, D. K. Lam, N. Blanas, C. M. L. Clokie, and G. K. B. Sándor, “Small mouths⋯big problems? A review of scleroderma and its oral health implications,” Journal of the Canadian Dental Association, vol. 73, no. 9, pp. 831–836, 2007. View at Google Scholar · View at Scopus
  28. LA. Dessy, M. Marcasciano, F. Pacitti, A. Rossi, and M. Mazzocchi, “A simple device for syringeto-syringe transfer during lipofilling,” Aesthetic Surgery Journal, vol. 35, no. 1, pp. 91–93, 2015. View at Google Scholar
  29. N. Scuderi, M. G. Onesti, G. Bistoni et al., “The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold,” Biomaterials, vol. 29, no. 11, pp. 1620–1629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Kwakkenbos, V. C. Delisle, R. S. Fox et al., “Psychosocial aspects of scleroderma,” Rheumatic Disease Clinics of North America, vol. 41, no. 3, pp. 519–528, 2015. View at Google Scholar
  31. B. D. Thombs, L. R. Jewett, L. Kwakkenbos, M. Hudson, and M. Baron, “Major depression diagnoses among patients with systemic sclerosis: baseline and one month followup,” Arthritis Care & Research, vol. 67, no. 3, pp. 411–416, 2015. View at Google Scholar
  32. C. Alfano, S. Chiummariello, P. Fioramonti, D. Innocenzi, and N. Scuderi, “Ultrastructural study of autologous cultivated conjunctival epithelium,” Ophthalmic Surgery, Lasers and Imaging, vol. 37, no. 5, pp. 378–382, 2006. View at Google Scholar · View at Scopus
  33. L. A. Dessy, M. Mazzocchi, F. Corrias, S. Ceccarelli, C. Marchese, and N. Scuderi, “The use of cultured autologous oral epithelial cells for vaginoplasty in male-to-female transsexuals: a feasibility, safety, and advantageousness clinical pilot study,” Plastic and Reconstructive Surgery, vol. 133, no. 1, pp. 158–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Maddali Bongi, A. Del Rosso, S. Mikhaylova et al., “District disability, fatigue and mood disorders as determinants of health related quality of life in patients with systemic sclerosis,” Joint Bone Spine, vol. 82, no. 1, pp. 67–68, 2015. View at Publisher · View at Google Scholar
  35. J. M. Gimble, A. J. Katz, and B. A. Bunnell, “Adipose-derived stem cells for regenerative medicine,” Circulation Research, vol. 100, no. 9, pp. 1249–1260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. K.-W. Minn, K.-H. Min, H. Chang, S. Kim, and E.-J. Heo, “Effects of fat preparation methods on the viabilities of autologous fat grafts,” Aesthetic Plastic Surgery, vol. 34, no. 5, pp. 626–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Condé-Green, N. F. G. de Amorim, and I. Pitanguy, “Influence of decantation, washing and centrifugation on adipocyte and mesenchymal stem cell content of aspirated adipose tissue: a comparative study,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 63, no. 8, pp. 1375–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kurita, D. Matsumoto, T. Shigeura et al., “Influences of centrifugation on cells and tissues in liposuction aspirates: optimized centrifugation for lipotransfer and cell isolation,” Plastic and Reconstructive Surgery, vol. 121, no. 3, pp. 1033–1043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Scuderi, S. Ceccarelli, M. G. Onesti et al., “Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis,” Cell Transplantation, vol. 22, no. 5, pp. 779–795, 2013. View at Publisher · View at Google Scholar · View at Scopus